Moderna Dividend yield

Moderna is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Moderna is a company from USA, and his stocks are publicly traded.

Moderna stock dividend

Moderna paid a total dividend of 0 million USD last year, for a market value of 43,645 millions (Market Cap 37,963 millions). Moderna dividend per share is 0.00 USD, and his stock market price 113.07 USD.

According to the chart below where dividend yield is displayed, Moderna, has a dividend yield of 0%, amount in contrast with the positive dividend offered by both the market average and companies from USA, Health Care industry, and Pharmaceuticals and Biotechnology sector. This lack of dividends of Moderna might harm the evolution of share price if the company is not clearly expanding his business.

In addition, you should compare Moderna stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the high USA dividend stocks list.

Moderna Dividend Payout

About the ability of Moderna to maintain his current dividend of USD 0.00 per share, an amount that accounts for 0.00%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Moderna payout on ernings is currently 0.00%, which is lower than the market average and companies in his industry and sector.

The following figure shows payout ratios over earnings and cashflow of Moderna, compared againt world market average, USA companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Moderna Dividend History

Below you will find a table with the historical evolution of Moderna's dividend stock, both in percentage and in USD, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	USD	Paypout	Shares*
Present	0.00%	0.00	0.00%	386
2022	0.00%	0.00	0.00%	384
2021	0.00%	0.00	0.00%	402

*In millions

Moderna Stock performance

Finally, last moth Moderna showed a return of -3.90% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a -14.50% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for USA and Pharmaceuticals and Biotechnology firms.